NCT06863038View on ClinicalTrials.gov

Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam

Not yet recruitingOBSERVATIONAL
Enrollment

572

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

March 17, 2027

Study Completion Date

November 30, 2027

Conditions
Lynch SyndromeColorectal Cancer (CRC)
Trial Locations (1)

700000

University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City

Sponsors

Collaborators (1)

Gene Solutions
All Listed Sponsors
collaborator

Gene Solutions

INDUSTRY

lead

University of Medicine and Pharmacy at Ho Chi Minh City

OTHER

NCT06863038 - Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam | Biotech Hunter | Biotech Hunter